Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.

The tumour had begun as a dull ache. Nothing serious – just a nagging throb at the back of his head. But month after month, the pain grew sharper, heavier, unrelenting. One afternoon, when the cattle ...